Abstract
Due to the requirement for comprehensive clinical research efforts in China, the importance of biobanking in modern clinical research is outlined in this overview. Hospitals, universities and research institutes have been well organized as fundamental resources for Chinese biobanking initiatives and the resulting bio-sample collections. Here, a brief history and time line of development of biobanking in China will be introduced, as well as strategic designs for future biobanking development.
This chapter was originally published in “The State of Oncology Africa, 2015” which was published and distributed by the International Prevention Research Institute of 95 cours Lafayette, Lyon France under ISBN 978-953-9268-3-5, in 2016.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Animal Germplasm Repository Construction and Management Norm(Shenzhen Standarlized Guiding Document No. SZDB/Z 91-2014), Human Biorepository Construction and Management Norm (No. SZDB/Z 92-2014) and Biological Genetic Information Database Construction and Management Norm (No. SZDB/Z 92-2014) were published in January 23rd 2014, which were collaboratively written by Shenzhen Administration of Market and Quality Supervision and Management, CNGB and Shenzhen Institute of Standards and Technology.
References
Chu JY, Xu JJ, Fu SB et al (2008) The establishment of the immortalize cell bank of different Chinese ethnic groups. Int J Genet 31(4):241–247
Sung WC (2008) Risk and the development of biobanking in China. In: Margaret SF (ed) Human genetic biobanks in Asia: politics of trust and scientific advancement. Routledge Contemporary Asia Series, London, pp 168–180
Cao ZF, Cao YR, Ma LG et al (2008) Standardization for sharing and utilization of Chinese genetic resources. Yi Chuan 30(1):51–58
Standardized organization, integration and shared pilot of genetic resources for Significant diseases (2005–2007) http://www.most.gov.cn/tztg/200906/W020090610602262555897.doc
Outline of the National Program for Long- and Medium-Term Scientific and Technological Development (2006–2020). http://www.gov.cn/jrzg/2006-02/09/content_183787.htm
Major science and technology project on Significant New Drugs Development http://www.most.gov.cn/tztg/201005/W020100514328917816412.pdf
Beijing Biobank of Clinical Resources http://www.beijingbiobank.cn/cn/index.aspx
Shanghai Science and Technology Progress report 2013 http://www.stcsm.gov.cn/newspecial/2013jb/ym2.html
Shanghai strategic emerging industries for the twelfth five-years plan http://www.shanghai.gov.cn/shanghai/node2314/node2319/node2404/node29352/node29353/u26ai30764.html
China National Genebank. http://www.nationalgenebank.org/en/
Prospective Study Of Chronic Diseases In China (China Kadoorie Biobank) http://www.kscdc.net/index.asp?accessdenied=%2Flist%2Easp%3Fchannel%3D10
Wang XF, Lu M, Qian J et al (2009) Rationales, design and recruitment of the Taizhou longitudinal study. BMC Public Health 9:223
Liu M, Hu QL (2014) A proposed approach to informed consent for biobanks in China. Bioethics 28(4):181–186
Ma Y, Dai HL, Wang LM et al (2012) Consent for use of clinical leftover biosample: a survey among Chinese patients and the general public. PLoS One 7(4):e36050
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Gan, R., Wang, H., Song, Y., Fan, J., Xiong, Y. (2017). Chinese Biobanking Initiatives. In: Hainaut, P., Vaught, J., Zatloukal, K., Pasterk, M. (eds) Biobanking of Human Biospecimens. Springer, Cham. https://doi.org/10.1007/978-3-319-55120-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-55120-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55118-0
Online ISBN: 978-3-319-55120-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)